Post by
OTCLegenda on Aug 23, 2022 10:33am
only product on the market today employing the OGM system
a strong product that could play an integral role in genome analysis and generate a healthy profit from the increasing footprint of the genetic medicines and research market. In a research note issued on July 18, Francois Brisebois at Oppenheimer gave Bionano Genomics stock a target price of $12 with an Outperform rating.
Comment by
Legarsdunord on May 18, 2023 3:30pm
A year later and it's under a buck.